Delineated domain of VP2 capsid protein in H-1 parvovirus that determines susceptibility to human cancer cells
Journal of Microbiology · 31.05.2026 · 64 (5) · e2601003
DOI: 10.71150/jm.2601003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Microbiology, erschienen am 31.05.2026. Verfasst von Il-Rae Cho und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cogno-Mechatronics Engineering, Optomechatronics Research Institute, Pusan National University, Busan 46241, Republic of Korea. Hauptthemen laut MEDLINE: Capsid Proteins, H-1 parvovirus, Oncolytic Viruses. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Pusan National University.
Abstract (Originalsprache)
Despite the application of H-1 parvovirus as an anticancer drug, the relationship between its specific tropism and oncolytic activity has been unknown. H-1 viral infection induced cytopathic effects in HeLa cells, whereas Kilham rat virus (KRV), similar to H-1 virus, did not. To explore which segments of the viral protein 2 (VP2) capsid protein in the H-1 virus determine susceptibility to human cancer cells, chimeric H-1 viruses with specific gene segments of H-1 VP2 were constructed. Delineation of the VP2 capsid protein revealed a minimum domain (K208–L435 in the H-1 VP2 protein) to determine infectivity in human cancer cells; however, this domain was not sufficient to maintain infectivity. To solve this problem, further construction of chimeric H-1 viruses illustrated the necessity of segments covering both M1-N87 and D104-P206 in the H-1 VP2 protein, based on chimeric H-1 viruses designated as YCH44, YCH45, and YCH46. Both the variable region 4b (VR4b) domains from KRV VP2 and VR8 from H-1 VP2 were required for the same purpose, based on chimeric H-1 viruses designated as YCH-HK8, YCH16, YCH17, YCH18, and YCH19. We confirmed that chimeric viruses carrying these segments infected human lung adenocarcinoma A549 and pancreatic cancer Panc-1 cells, whereas the parental KRV did not. Taken together, these findings indicate that specific domains of the H-1 virus VP2 capsid protein determine infectivity toward human cancer cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cogno-Mechatronics Engineering, Optomechatronics Research Institute, Pusan National University, Busan 46241, Republic of Korea.
- Department of Integrated Biological Science, Pusan National University, Busan 46241, Republic of Korea.
- Department of Microbiology, School of Medicine, Gyeongsang National University, Jinju 52828, Republic of Korea.
- Department of Microbiology, Sungkyunkwan University School of Medicine, Suwon 16419, Republic of Korea.
Förderung
- Pusan National University
Zitieren
APA
Cho, I. R., Budluang, P., Kim, Y. H., Park, H., Kim, N., Lee, K. H., Ahn, J. H., Kang, H. Y., & Chung, Y. H. (2026). Delineated domain of VP2 capsid protein in H-1 parvovirus that determines susceptibility to human cancer cells. Journal of Microbiology, 64(5), e2601003. https://doi.org/10.71150/jm.2601003
Vancouver
Cho IR, Budluang P, Kim YH, Park H, Kim N, Lee KH, et al. Delineated domain of VP2 capsid protein in H-1 parvovirus that determines susceptibility to human cancer cells. Journal of Microbiology. 2026;64(5):e2601003. doi:10.71150/jm.2601003
BibTeX
@article{Cho2026,
author = {Cho, Il-Rae and Budluang, Patcharporn and Kim, Yeon Ha and Park, Haan and Kim, Namuk and Lee, Kon Ho and Ahn, Jin-Hyun and Kang, Ho Young and Chung, Young-Hwa},
title = {Delineated domain of VP2 capsid protein in H-1 parvovirus that determines susceptibility to human cancer cells},
journal = {Journal of Microbiology},
year = {2026},
volume = {64},
number = {5},
pages = {e2601003},
doi = {10.71150/jm.2601003}
}
EUVIMED